Oncotarget. 2018 Mar 30;9(24):17014-17027. doi: 10.18632/oncotarget.24795. eCollection 2018 Mar 30.
García-Salum T1,2, Villablanca A1,2, Matthäus F3, Tittarelli A1,2, Baeza M4, Pereda C1,2, Gleisner MA1,2, González FE2,5, López MN1,2, Hoheisel JD6, Norgauer J7, Gebicke-Haerter PJ1,8, Salazar-Onfray F1,2.
Author information
1 Disciplinary Program of Immunology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, 8380453 Santiago, Chile.
2 Millennium Institute on Immunology and Immunotherapy, Faculty of Medicine, Universidad de Chile, 8380453 Santiago, Chile.
3 Faculty of Biological Sciences and FIAS, University of Frankfurt, Ruth-Moufang-Straße 1, 60438 Frankfurt am Main, Germany.
4 Laboratory of Periodontal Biology, Faculty of Dentistry, Universidad de Chile, 8380492 Santiago, Chile.
5 Laboratory of Experimental Immunology and Cancer, Faculty of Dentistry, Universidad de Chile, 8380492 Santiago, Chile.
6 Functional Genome Analysis, German Cancer Research Centre (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
7 Department of Dermatology, Jena University Hospital D-07743 Jena, Germany.
8 Institute of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, J5, 68159 Mannheim, Germany.
